San Diego HIV Community Consortium (SDHIVC)

MEETING AGENDA

Saturday, September 5, 2026

11:00 AM – 12:15 PM

11:00 AM

Welcome and Call to Order

11:05 AM – 11:35 AM

IDVYNSO™ (doravirine/islatravir): A New HIV Treatment Option

Presenter: Bill Sanders, Merck & Co., Inc

Presentation and discussion regarding IDVYNSO™, a once-daily, single-tablet, two-drug regimen recently approved by the FDA for virologically suppressed adults with HIV-1 who meet specific treatment criteria. IDVYNSO combines doravirine and islatravir and represents the first FDA-approved, non-INSTI, tenofovir-free, complete two-drug oral regimen for maintaining viral suppression in eligible adults.

11:35 AM – 12;00 PM

Review of AIDS 2026, International AIDS Conference, Rio de Janeiro

What’s New in HIV Highlights from IAS 2026 Rio

Presenter: Jason Cuneo, BA

Community Education Director, San Diego HIV Community Consortium

Senior Services Program Manager, The San Diego LGBT Community Center

Board Member, POZabilities

12:00 PM – 12:15 PM

Questions, Community Discussion & Announcements

Open discussion and audience questions regarding AIDS 2026 highlights, HIV treatment advances, prevention strategies, and emerging research.

The October San Diego HIV Community Consortium meeting will return to The San Diego LGBT Community Center

3909 Centre Street, San Diego, CA 92103

Saturday, October 3, 2026

Lunch Provided by AHF

One time CHANGE OF LOCATION

AHF 3580 Fifth Ave, SD, CA  92103

2^nd floor

Click to connect on ZOOM or See us Live!